Inhibition of vascular endothelial growth factor‐A downregulates angiogenesis in psoriasis: A pilot study
Abstract Background Vascular Endothelial Growth Factor (VEGF)‐A‐mediated angiogenesis participates in the pathogenesis of psoriasis, thus inviting the hypothesis that anti‐VEGF‐A therapy could be beneficial in psoriasis. While anti‐angiogenic agents are used in oncology and ophthalmology, these ther...
Main Authors: | Andrea Luengas‐Martinez, Dina Ismail, Ralf Paus, Helen S. Young |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-10-01
|
Series: | Skin Health and Disease |
Online Access: | https://doi.org/10.1002/ski2.245 |
Similar Items
-
Clopidogrel inhibits angiogenesis of gastric ulcer healing via downregulation of vascular endothelial growth factor receptor 2
by: Jiing-Chyuan Luo, et al.
Published: (2016-09-01) -
Vascular endothelial growth factor biology for regenerative angiogenesis
by: Andrea Uccelli, et al.
Published: (2019-01-01) -
Vascular Endothelial Growth Factor A VEGFA Inhibition: An Effective Treatment Strategy for Psoriasis
by: Ya Chen, et al.
Published: (2023-12-01) -
Assessing the association between psoriasis and cardiovascular ischemia: An investigation of vascular endothelial growth factor, cutaneous angiogenesis, and arterial stiffness
by: Alpana Mohta, et al.
Published: (2023-01-01) -
Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis
by: Xu, H, et al.
Published: (2013)